The classification of ampullary adenocarcinoma into intestinal and pancreatobiliary sub-types has been found to be important in predicting prognosis and determining therapeutic strategy. Due to considerable inter-observer variability in sub-typing based solely on morphology, higher frequency of poorly differentiated cancers and low incidence of the disease, the histomorphologic classification of ampullary adenocarcinoma remains one of the grey zones in surgical pathology. Pan-IN is a well recognized precursor to pancreatic adenocarcinoma. Three studies have shown concurrent Pan-IN in patients with ampullary carcinoma, but their association with the two sub-types has not yet been reported. Fourteen cases of surgical resection for ampullary adenocarcinoma were retrieved from the archives. The cases were classified into two groups based on the presence or absence of concomitant Pan-IN. All the cases were stained for CK7, CK 20, Villin and CDX 2 and were classified as intestinal or pancreatobiliary types based on the staining pattern. All the 10 cases with Pan-IN stained negative for CDX2 and were classified as pancreatobiliary type (p = 0.01). Of the cases without Pan-IN, 3 were classified as intestinal sub-type based on morphology and CDX2 positivity and 1 was classified as pancreatobiliary type. Concomitant Pan-IN was present in 91% of pancreatobiliary type of ampullary adenocarcinoma. The grade of Pan-IN did not influence the grade or stage of the adenocarcinoma (p > 0.05). The co-occurrence of Pan-IN in a high percentage of the pancreatobiliary sub-type and its complete absence in the intestinal sub-type may serve as a strong differentiator between the two sub-types.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Albores-Saavedra J, Schwartz AM, Batich K, Henson DE (2009) Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 100:598–605
Benhamiche AM, Jouve JL, Manfredi S, Prost P, Isambert N et al (2000) Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol 12:75–79
Winter JM, Cameron JL, Olino K, Herman JM, Jong MC et al (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14:379–387
Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, Esaki Y (1994) Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85(2):161–166
Bronsert P, Kohler I, Werner M, Makowiec F, Kuesters S, Hoeppner J, Hopt UT, Keck T, Bausch D, Wellner UF (2013) Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin. BMC Cancer 13:428
Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F et al (2009) Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol 33:691–704
Albores-Saavedra J, Henson DE, Klimstra DS (2000) Malignant tumors of the ampulla. In:Tumors of the gallbladder extrahepatic bile ducts and ampulla of vater Armed Forces Institute of Pathology. Washington D.C, 259–316
Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OPF, Gladhaug IP (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMCCancer 8:170
Rosa VDL, Peria FM, Brunaldi MO (2017) Carcinoma of ampulla of Vater: carcinogenesis and Immunophenotypic evaluation. J Clin Epigenet 3(2):25
Ang DC, Shia J, Tang LH (2014) The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of Vater. Am J Surg Pathol 38:1371–1379
Chang DK, Jamieson NB, Johns AL (2013) Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J Clin Oncol 31:1348–1356
Liu TH, Chen J, Zeng XJ (1983) Histogenesis of pancreatic head and ampullary region carcinoma. Chin Med J 96:167–174
Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE et al (2001) Neoplasms of the ampulla of Vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 14:139–143
Cattel RB, Pyrtek LJ (1949) An appraisal of pancreatoduodenal resection: a follow-up study of 61 cases. Ann Surg 129:840–848
Kimura W, Futakawa N, Zhao B (2004) Neoplastic diseases of the papilla of Vater. J Hepato-Biliary-Pancreat Surg 11:223–231
Zhou H, Schaefer N, Wolff M, Fischer H (2004) Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875–882
Fischer HP, Zhou H (2000) Pathologie der Papilla Vateri. In: Doerr W, Seifert G, Uehlinger E (eds) Spezielle Pathologische Anatomie: Pathologie der Leber und der Gallenwege, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1219–1257
Sessa F, Furlan D, Zampatti C, Carnevali I, Franzi F, Capella C (2007) Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch 451:649–657
Schueneman A, Wang H, Soifer HS, Schnabel CA, Wolff RA, Varadhachary GR, Overman MJ (2014) Molecular classification of ampullary adenocarcinoma: comparative prognostic performance of the 92-gene assay versus histomolecular analysis. J Clin Oncol 32(15):4141–4141
Perkins G, Svrcek M, Bouchet-Doumenq C, Voron T, Colussi O, Debove C, et al. (2019) Can we classify ampullary tumours better? Clinical, pathological and molecularfeatures. Results of an AGEO study. Br J Cancer [Epub ahead of print]
Jeong BK, Sung YN, Kim SJ, An S, Park H, Hwang HS, Kang HJ, Lee JH, Song KB, Kim KP, Hwang DW, Lee SS, Kim SC, Hong SM (2019) High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas. Hum Pathol 84:92–104
KK and VS conceived and designed the study, aquired and analysed the data and drafted the article. VS reviewed the slides and the stains and revised the manuscript critically for important intellectual content.
Conflict of Interest
The authors declare that there is no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Krishnamurthy, K., Sriganeshan, V. Pancreatic Intraepithelial Neoplasia (PanIN) as a Morphologic Marker of Pancreatobiliary Type of Ampullary Carcinoma. Pathol. Oncol. Res. 26, 1735–1739 (2020). https://doi.org/10.1007/s12253-019-00754-6
- Pancreatic intraepithelial neoplasia (pan-IN)
- Ampullary adenocarcinoma and its sub-types
- Pancreatic adenocarcinoma